STUDY SEARCH RESULTS

1 study found for your search request:  3475-C11

Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed ...
Condition: Classical Hodgkin Lymphoma
Minimum Age: 18, Maximum Age: N/A
Gender: All
Study ID: NCT05008224
Status: Completed
Has Results




Copyright © 2026 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site